Showing results (161-170 of 764) with videos related to
Sort By:
Pageof 77
Urologic Oncology|August 23, 2017
Outcomes of men on active surveillance for low-risk prostate cancer at a safety-net hospitalE Charles Osterberg, Nynikka R A Palmer, Catherine R Harris, et al.Biorxiv : the Preprint Server for Biology|June 9, 2020
Expression of ACE2, the SARS-CoV-2 receptor, and TMPRSS2 in prostate epithelial cellsHanbing Song, Bobak Seddighzadeh, Matthew R Cooperberg, et al.The Journal of Urology|March 23, 2011
The relationship between prostate specific antigen change and biopsy progression in patients on active surveillance for prostate cancerJared M Whitson, Sima P Porten, Joan F Hilton, et al.Frontiers in Urology|August 8, 2025
Controlled trial of decision support for men with early-stage prostate cancer: brief research report of effects on patient knowledgeJeffrey K Belkora, Jeanette M Broering, John Neuhaus, et al.European Urology Focus|May 15, 2025
Gleason Grade Group 3 Represents a Spectrum of Disease: Results from a Large Institutional CohortKevin Shee, Janet E Cowan, Chien-Kuang Cornelia Ding, et al.Cancer|January 27, 2024
The impact of genomic biomarkers on a clinical risk prediction model for upgrading/upstaging among men with favorable-risk prostate cancerAvery E Braun, June M Chan, John Neuhaus, et al.The Urologic Clinics of North America|November 7, 2017
Whom to Treat: Postdiagnostic Risk Assessment with Gleason Score, Risk Models, and Genomic ClassifierAnnika Herlemann, Samuel L Washington, Renu S Eapen, et al.Translational Andrology and Urology|July 28, 2018
Genomic biomarkers in prostate cancerZachary Kornberg, Matthew R Cooperberg, Daniel E Spratt, et al.Current Opinion in Urology|February 22, 2017
Impact of the United States Preventive Services Task Force 'D' recommendation on prostate cancer screening and stagingRenu S Eapen, Annika Herlemann, Samuel L Washington, et al.Urology|May 27, 2023
The Long-term Incidence and Quality of Life Outcomes Associated With Treatment-Related Toxicities of External Beam Radiotherapy for Prostate CancerPeter E Lonergan, Avi Baskin, Scott A Greenberg, et al.Pageof 77